BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8847525)

  • 1. Targeted infection of a retrovirus bearing a CD4-Env chimera into human cells expressing human immunodeficiency virus type 1.
    Matano T; Odawara T; Iwamoto A; Yoshikura H
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3165-9. PubMed ID: 8847525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.
    Schnierle BS; Moritz D; Jeschke M; Groner B
    Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insertion of targeting domains into the envelope glycoprotein of Moloney murine leukemia virus (MoMLV)-based vectors modulates the route of mCAT-1-mediated viral entry.
    Viejo-Borbolla A; Pizzato M; Blair ED; Schulz TF
    Virus Res; 2005 Mar; 108(1-2):45-55. PubMed ID: 15681054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An essential role for the His-8 residue of the SDF-1alpha-chimeric, tropism-redirected Env protein of the Moloney murine leukemia virus in regulating postbinding fusion events.
    Katane M; Fujita R; Takao E; Kubo Y; Aoki Y; Amanuma H
    J Gene Med; 2004 Mar; 6(3):260-7. PubMed ID: 15026987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of simian virus 5 fusion protein into murine leukemia virus particles and its effect on the co-incorporation of retroviral envelope glycoproteins.
    Hatziioannou T; Russell SJ; Cosset FL
    Virology; 2000 Feb; 267(1):49-57. PubMed ID: 10648182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudotyping of Moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cells.
    Indraccolo S; Minuzzo S; Feroli F; Mammano F; Calderazzo F; Chieco-Bianchi L; Amadori A
    Gene Ther; 1998 Feb; 5(2):209-17. PubMed ID: 9578840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in infectivity of targeted Moloney murine leukemia virus-based gene-delivery vectors through lowering the threshold for fusion.
    Viejo-Borbolla A; Thomas P; Blair ED; Schulz TF
    J Gen Virol; 2005 Sep; 86(Pt 9):2469-2480. PubMed ID: 16099905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles.
    Höhne M; Thaler S; Dudda JC; Groner B; Schnierle BS
    Virology; 1999 Aug; 261(1):70-8. PubMed ID: 10441556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postbinding fusion function contributed by a chimeric murine leukemia virus envelope protein.
    Nakamura H; Takeda A; Matano T
    Arch Virol; 2001; 146(5):953-61. PubMed ID: 11448032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. trans-dominant interference with virus infection at two different stages by a mutant envelope protein of Friend murine leukemia virus.
    Matano T; Odawara T; Ohshima M; Yoshikura H; Iwamoto A
    J Virol; 1993 Apr; 67(4):2026-33. PubMed ID: 8445721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting retroviral vectors to vascular lesions by genetic engineering of the MoMLV gp70 envelope protein.
    Hall FL; Gordon EM; Wu L; Zhu NL; Skotzko MJ; Starnes VA; Anderson WF
    Hum Gene Ther; 1997 Dec; 8(18):2183-92. PubMed ID: 9449372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells.
    Mammano F; Salvatori F; Indraccolo S; De Rossi A; Chieco-Bianchi L; Göttlinger HG
    J Virol; 1997 Apr; 71(4):3341-5. PubMed ID: 9060707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human immunodeficiency virus type 1 Vpu protein tethered to the CD4 extracellular domain is localized to the plasma membrane and is biologically active in the secretory pathway of mammalian cells: implications for the mechanisms of Vpu function.
    Raja NU; Jabbar MA
    Virology; 1996 Jun; 220(1):141-51. PubMed ID: 8659106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
    Junker U; Böhnlein E; Veres G
    Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted infection of HIV-1 Env expressing cells by HIV(CD4/CXCR4) vectors reveals a potential new rationale for HIV-1 mediated down-modulation of CD4.
    Ye Z; Harmison GG; Ragheb JA; Schubert M
    Retrovirology; 2005 Dec; 2():80. PubMed ID: 16371160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
    Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L
    Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviral vector-mediated expression in primary human T cells of an endoplasmic reticulum-retained CD4 chimera inhibits human immunodeficiency virus type-1 replication.
    San José E; Muñoz-Fernández MA; Alarcón B
    Hum Gene Ther; 1998 Jun; 9(9):1345-57. PubMed ID: 9650619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
    Deml L; Kratochwil G; Osterrieder N; Knüchel R; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):10-25. PubMed ID: 9300033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of tumor vasculature targeting motifs into moloney murine leukemia virus env escort proteins enhances retrovirus binding and transduction of human endothelial cells.
    Liu L; Anderson WF; Beart RW; Gordon EM; Hall FL
    J Virol; 2000 Jun; 74(11):5320-8. PubMed ID: 10799609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
    Otteken A; Voss G; Hunsmann G
    Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.